Abstract
Abstract
Background Single brain metastasis surgical resection remains an effective treatment for brain metastases. However, surgery alone associate with a high rate of local failure. The current guidelines recommend radiation to surgical cavity. The recommended dose for brain cavity after surgery remain to be define as most guidelines gives a very general suggestion about the dose and fractionation. The aim of this study was to determine what variable influence local control in this specific population.Methods Retrospective analysis of 52 patients with breast cancer who undergo surgical resection to single brain metastases and who received post-operative radiotherapy between the years 2010–2022. All clinical and dosimetric variables were analyzed to evaluate their impact on local control. A predictive model for local control was calculated.Results One year local control was 65.3%. HER-2 disease, size of initial tumor, time from initial surgery, total dose deliver and the type of lesion were all significant for local control. The most important variable was total dose deliver. A specific nomogram using 7 parameters for a prediction of local was computed.Conclusion Brain metastases from breast cancer remain a life-threating condition. Surgery plays a critical role in the treatment of large symptomatic brain metastases for which Post-operative radiotherapy is essential. Choosing a regime of 5 fraction with a dose of 30Gy (BED4 > 70Gy) seem important for achieving local control and without increase toxicity.
Publisher
Research Square Platform LLC
Reference21 articles.
1. Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies;Yajie;Br J Cancer,2021
2. Brain metastases originating in breast cancer: clinical-pathological analysis and immunohistochemical profile;Sava A;Rom J Morphol Embryol 2021 Apr-Jun
3. Surgical Management of Brain Metastasis: Challenges and Nuances;Chibawanye I;Front Oncol,2022
4. Patchell RA et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial, vol 280. JAMA, pp 1485–1489. 17
5. Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952–26001 Study;Kocer M;J Clin Oncol,2011